Xylem Raises FY2026 Adj EPS Guidance from $5.35-$5.56 to $5.35-$5.60 vs $5.49 Est; Raises FY2026 Sales Guidance from $9.100B-$9.200B to $9.200B-$9.300B vs $9.195B Est

Benzinga Newsdesk www.benzinga.com Positive 83.1%

Neg 0% Neu 0% Pos 83.1%

Xylem (NYSE:XYL) raises FY2026 Adj EPS guidance from $5.35-$5.56 to $5.35-$5.60 vs $5.49 analyst estimate. Raises FY2026 sales outlook from $9.100 billion-$9.200 billion to $9.200 billion-$9.300 billion vs $9.195 billion estimate.